Fu YX - Search Results

1

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance.

Liang Y, Tang H, Guo J, Qiu X, Yang Z, Ren Z, Sun Z, Bian Y, Xu L, Xu H, Shen J, Han Y, Dong H, Peng H, Fu YX. Liang Y, et al. Among authors: fu yx. Nat Commun. 2018 Nov 2;9(1):4586. doi: 10.1038/s41467-018-06890-y. Nat Commun. 2018. PMID: 30389912 Free PMC article.

2

Adaptive immune cells temper initial innate responses.

Kim KD, Zhao J, Auh S, Yang X, Du P, Tang H, Fu YX. Kim KD, et al. Among authors: fu yx. Nat Med. 2007 Oct;13(10):1248-52. doi: 10.1038/nm1633. Epub 2007 Sep 23. Nat Med. 2007. PMID: 17891146 Free PMC article.

3

The tumor immunosuppressive microenvironment impairs the therapy of anti-HER2/neu antibody.

Xu M, Du X, Liu M, Li S, Li X, Fu YX, Wang S. Xu M, et al. Among authors: fu yx. Protein Cell. 2012 Jun;3(6):441-9. doi: 10.1007/s13238-012-2044-3. Epub 2012 Jun 20. Protein Cell. 2012. PMID: 22717982 Free PMC article.

4

Effective anti-neu-initiated antitumor responses require the complex role of CD4+ T cells.

Mortenson ED, Park S, Jiang Z, Wang S, Fu YX. Mortenson ED, et al. Among authors: fu yx. Clin Cancer Res. 2013 Mar 15;19(6):1476-86. doi: 10.1158/1078-0432.CCR-12-2522. Epub 2013 Jan 30. Clin Cancer Res. 2013. PMID: 23363817 Free PMC article.

5

A mouse model for HBV immunotolerance and immunotherapy.

Yang D, Liu L, Zhu D, Peng H, Su L, Fu YX, Zhang L. Yang D, et al. Among authors: fu yx. Cell Mol Immunol. 2014 Jan;11(1):71-8. doi: 10.1038/cmi.2013.43. Epub 2013 Sep 30. Cell Mol Immunol. 2014. PMID: 24076617 Free PMC article.

6

Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses.

Yang X, Zhang X, Fu ML, Weichselbaum RR, Gajewski TF, Guo Y, Fu YX. Yang X, et al. Among authors: fu ml, fu yx. Cancer Cell. 2014 Jan 13;25(1):37-48. doi: 10.1016/j.ccr.2013.12.004. Cancer Cell. 2014. PMID: 24434209 Free PMC article.

7

Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota.

Guo X, Liang Y, Zhang Y, Lasorella A, Kee BL, Fu YX. Guo X, et al. Among authors: fu yx. Immunity. 2015 Apr 21;42(4):731-43. doi: 10.1016/j.immuni.2015.03.012. Immunity. 2015. PMID: 25902484 Free PMC article.

8

Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication.

Liang Y, Yang K, Guo J, Wroblewska J, Fu YX, Peng H. Liang Y, et al. Among authors: fu yx. Sci Rep. 2015 May 20;5:10406. doi: 10.1038/srep10406. Sci Rep. 2015. PMID: 25993659 Free PMC article.

9

Deficiency of CD40 Reveals an Important Role for LIGHT in Anti-Leishmania Immunity.

Okwor I, Xu G, Tang H, Liang Y, Fu YX, Uzonna JE. Okwor I, et al. Among authors: fu yx. J Immunol. 2015 Jul 1;195(1):194-202. doi: 10.4049/jimmunol.1401892. Epub 2015 May 29. J Immunol. 2015. PMID: 26026056

10

CD47 blockade triggers T cell-mediated destruction of immunogenic tumors.

Liu X, Pu Y, Cron K, Deng L, Kline J, Frazier WA, Xu H, Peng H, Fu YX, Xu MM. Liu X, et al. Among authors: fu yx. Nat Med. 2015 Oct;21(10):1209-15. doi: 10.1038/nm.3931. Epub 2015 Aug 31. Nat Med. 2015. PMID: 26322579 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

598 results

Search Page

Filters